Total Payments
$2,150
2020 Payments
$91.40
Companies
31
Transactions
138
Medicare Patients
2,451
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$2,150 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,150 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $369.83 | 24 | $0 (2018) |
| Amgen Inc. | $340.48 | 23 | $0 (2019) |
| Astellas Pharma US Inc | $149.52 | 10 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $145.16 | 11 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $118.86 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $112.01 | 8 | $0 (2019) |
| Janssen Biotech, Inc. | $109.71 | 8 | $0 (2019) |
| Varian Medical Systems, Inc. | $106.97 | 1 | $0 (2017) |
| Celgene Corporation | $77.98 | 5 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $64.76 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $91.40 | 5 | Astellas Pharma US Inc ($22.19) |
| 2019 | $525.60 | 36 | Amgen Inc. ($102.62) |
| 2018 | $901.02 | 61 | Novartis Pharmaceuticals Corporation ($225.12) |
| 2017 | $632.47 | 36 | Novartis Pharmaceuticals Corporation ($144.71) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/20/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Oncology | ||||||
| 02/11/2020 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Hematology | ||||||
| 02/03/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: Hematology/Oncology | ||||||
| 01/28/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar, Vitrakvi | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Oncology | ||||||
| 01/22/2020 | Astellas Pharma US Inc | PADCEV (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Oncology | ||||||
| 12/13/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Oncology | ||||||
| 12/09/2019 | Amgen Inc. | KANJINTI (Biological), Nplate, XGEVA | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Oncology | ||||||
| 11/22/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.32 | General |
| Category: Oncology | ||||||
| 11/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $16.30 | General |
| 10/31/2019 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: Optune | ||||||
| 10/28/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Oncology | ||||||
| 10/21/2019 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Hematology / Oncology | ||||||
| 10/18/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Oncology | ||||||
| 10/15/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Oncology | ||||||
| 10/15/2019 | Taiho Oncology, Inc. | Lonsurf (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Oncology | ||||||
| 09/30/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Oncology | ||||||
| 08/20/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Oncology | ||||||
| 08/16/2019 | Amgen Inc. | MVASI (Biological), Neulasta, Vectibix | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Oncology | ||||||
| 08/12/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Oncology | ||||||
| 06/26/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Oncology | ||||||
| 06/21/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Oncology | ||||||
| 06/04/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| Category: Oncology | ||||||
| 06/04/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 20 | 1,078 | 7,208 | $5.3M | $1.1M |
| 2020 | 24 | 1,373 | 9,107 | $6.1M | $1.2M |
Total Patients
2,451
Total Services
16,315
Medicare Billing
$2.3M
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatments | Office | 2020 | 106 | 465 | $289,969 | $68,435 | 23.6% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2020 | 53 | 856 | $320,143 | $48,292 | 15.1% |
| 77334 | Radiation treatment devices, design and construction, complex | Office | 2020 | 104 | 374 | $196,771 | $36,576 | 18.6% |
| 77336 | Radiation therapy consultation per week | Office | 2020 | 110 | 481 | $165,267 | $28,185 | 17.1% |
| 77290 | Management of radiation therapy, simulation, complex | Office | 2020 | 61 | 72 | $130,840 | $27,448 | 21.0% |
| 77280 | Management of radiation therapy simulation, simple | Office | 2020 | 65 | 117 | $110,996 | $24,896 | 22.4% |
| 77295 | Management of radiation therapy, 3d | Office | 2020 | 52 | 60 | $236,348 | $22,691 | 9.6% |
| 77338 | Design and construction of device for radiation therapy | Office | 2020 | 43 | 57 | $94,079 | $21,719 | 23.1% |
| 77263 | Management of radiation therapy, complex | Office | 2020 | 97 | 103 | $59,613 | $13,663 | 22.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 144 | 192 | $45,708 | $10,105 | 22.1% |
| 77331 | Special radiation therapy planning | Office | 2020 | 51 | 163 | $35,620 | $8,349 | 23.4% |
| 77307 | Radiation therapy plan | Office | 2020 | 14 | 16 | $31,010 | $3,651 | 11.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 39 | 39 | $13,802 | $3,296 | 23.9% |
| 77470 | Special radiation treatment procedure | Office | 2020 | 31 | 31 | $50,047 | $3,287 | 6.6% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 49 | 49 | $11,996 | $2,852 | 23.8% |
| 77370 | Radiation therapy consultation | Office | 2020 | 16 | 16 | $6,354 | $1,400 | 22.0% |
| 77321 | Radiation therapy total body port plan | Office | 2020 | 13 | 15 | $12,848 | $1,119 | 8.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 15 | $2,363 | $880.92 | 37.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 12 | $1,712 | $390.35 | 22.8% |
About Dr. Charles Thomas, MD
Dr. Charles Thomas, MD is a Radiation Oncology healthcare provider based in Clyde, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447200738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Thomas, MD has received a total of $2,150 in payments from pharmaceutical and medical device companies, with $91.40 received in 2020. These payments were reported across 138 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,150).
As a Medicare-enrolled provider, Thomas has provided services to 2,451 Medicare beneficiaries, totaling 16,315 services with total Medicare billing of $2.3M. Data is available for 2 years (2020–2021), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Clyde, NC
- Active Since 05/10/2006
- Last Updated 12/09/2009
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1447200738
Products in Payments
- VOTRIENT (Drug) $138.18
- Aranesp (Biological) $127.88
- Kyprolis (Biological) $109.48
- TrueBeam (Device) $106.97
- XTANDI (Drug) $101.41
- LYNPARZA (Drug) $94.73
- KISQALI (Drug) $91.03
- Neulasta (Biological) $71.83
- AFINITOR (Drug) $67.42
- Erleada (Drug) $65.54
- Lenvima (Drug) $60.34
- NINLARO (Drug) $60.10
- Cabometyx (Drug) $56.31
- Aliqopa (Drug) $55.61
- KEYTRUDA (Biological) $54.06
- JAKAFI (Drug) $42.53
- MEKINIST (Drug) $41.73
- Lonsurf (Drug) $40.63
- OPDIVO (Biological) $39.75
- Vitrakvi (Drug) $37.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.